Upcoming webinar

Redefining HNSCC management with Signatera™ MRD testing: A multidisciplinary perspective

Date: Friday, June 26, 2026

Time: 5 PM PDT / 8 PM EDT (60-minute webinar)

Registrants will receive a recording of the webinar approximately one week after the event.

Join a multidisciplinary panel for a live webinar on the latest clinical data supporting Signatera™ ctDNA molecular residual disease (MRD) testing in HNSCC patient care. Hear how each specialist integrates Signatera™ into their practice and coordinates patient handoffs across surgery, radiation, and medical oncology.

The discussion will cover how Signatera™ MRD testing:

Helps determine recurrence risk after curative-intent treatment
Detects recurrence early
Helps inform treatment management across HPV-negative and HPV-positive HNSCC

Natera Honey Pot

Register Now:

First Name*

Last Name*

Email Address*

Job Title*

Phone*

Company Name*

Postal Code*

Country*

I am a*

Do you have any questions for the presenters that you would like to submit before the webinar?

Please fill in the field above only if you have specific questions. Otherwise, leave it blank.

Natera would like to send you information about our products and services. You may unsubscribe from these communications at any time.

address1

Hear from our speakers:

Jonathan D. Schoenfeld, MD, MPhil, MPH

Director of Head and Neck Radiation Oncology at Dana-Farber Brigham Cancer Center, and MGB Endowed Chair in Radiation Oncology

Mihir R. Patel, MD

Professor and Chief of the Division of Head and Neck Surgical Oncology

University of North Carolina at Chapel Hill

Siddharth Sheth, DO, MPH

Associate Professor of Medicine (Medical Oncology) and

Leader of the Head & Neck Cancer Clinical Research Group

University of North Carolina at Chapel Hill

Michael Krainock, MD, PhD

Medical Director

Oncology Natera

Signatera™ has been developed and its performance characteristics determined by the CLIA-certified laboratory performing the test. The test has not been cleared or approved by the US Food and Drug Administration (FDA). CAP accredited, ISO 13485 certified, and CLIA certified. © 2026 Natera, Inc. All Rights Reserved.

13011 McCallen Pass, Building A Suite 100 | Austin, TX 78753 | natera.com | Do Not Share My Personal Information | Privacy Policy